Flyte Aviation Signs Letter of Intent to Sell Cardiology Assets

PUBT · 17h ago
Flyte Aviation Signs Letter of Intent to Sell Cardiology Assets
  • Flyte Aviation signed a non-binding letter of intent to sell Catheter Precision's VIVO, LockeT and associated life sciences assets.
  • Closing is targeted by year-end 2026, with cash consideration payable at completion.
  • Contingent payments depend on specified monetization events or value thresholds within six years of closing.
  • The sale would complete the transition to a technology-enabled private aviation business while significantly reducing operating expenses.
  • Proceeds would strengthen the balance sheet and fund fleet expansion, growth initiatives and improved aircraft utilization.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flyte Aviation Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611041615PR_NEWS_USPR_____NY89392) on November 04, 2026, and is solely responsible for the information contained therein.